Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.

In conclusion, circulatory MALAT1 might represent a putative non-invasive prognostic biomarker indicating worse liver failure score in HCV-related HCC patients with traditional markers. Large-scale verification is warranted in future studies. PMID: 29604585 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29604585?dopt=Abstract

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 28, 2018 Category: Drugs & Pharmacology Authors: Toraih EA, Ellawindy A, Fala SY, Al Ageeli E, Gouda NS, Fawzy MS, Hosny S Tags: Biomed Pharmacother Source Type: research